undefined

Michael Hufford

Co-founder and CEO of LyGenesis, a regenerative medicine company developing a cell‑based therapy to grow functional ectopic livers in patients' lymph nodes; discussed the science, trials, and clinical rationale for the therapy.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app